Skip to content

To Study The Effect Of Krimighanadi Kashaya In Obesity

A Randomized Clinical Study On Krimighanadi Kashaya In Sthoulya With Special Reference To Obesity - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098982
Enrollment
30
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight

Interventions

None listed

Sponsors

Jammu Institute Of Ayurveda And Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex of age between 18years to 60 years. 2.Patients having signs and symptoms of Obesity like large body frame having extra fat around the waist, difficulty in doing daily activities, lethargy, breathlessness increased weight, snoring, having sweating difficulty while sleeping. 3.Patients having classical signs and symptoms of Sthoulya like Chal Udara Stana Sphika, Javoparodha, Kruchvyavaya, Dourbalyta , Atikshudha, Atitrishna etc. 4.Patients with BMI between 25kg/m2 to 39 kg/m2 5.Patients willing to participate and able to provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients age less than 18 and more than 60 years. 2.Pathophysiology or Genetic Syndromes associated with Sthoulya. 3.Malignancy, poorly controlled diabetes mellitus, hypertension. 4.Patients suffering from pulmonary diseases, cardiac diseases will not be taken from study. 5.Alcoholic and drug abusers, pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Improvement in Subjective and objective Parameters of Sthoulya Subjective:. Dourgandya Ang Gourava,Utsaha Hani,Kshudra Swasa,Ati Pipasa, Chala Spikha Udara Stana,Dourbalya,Nidraadhikya,Swedadhikya Snigdhangata,Alpa Vyavaya Objective:Body Mass IndexTimepoint: Assessment: Percentage relief in symptoms and signs after 30 days of treatment.

Secondary

MeasureTime frame
1.Change in Quality-of-Life Indicators 2.Improvement in Functional Capacity 3.Overall Therapeutic Response AssessmentTimepoint: Assessment after drug free period

Countries

India

Contacts

Public ContactDr Apurva Gupta

Jammu Institute Of Ayurveda And Research

Dr.nitinmahajan1608@gmail.com9419119123

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026